韩国全国性队列:腹腔镜抗反流手术趋势与1年结局
该研究基于韩国抗反流手术研究(KARS)全国队列,分析截至2018年接受抗反流手术的310例GERD患者,评估术后3个月和1年的症状缓解与并发症。结果显示典型症状完全或部分控制率达90.3%,并发现2011至2018年手术量持续增加、后期手术时间显著缩短,而症状控制与并发症发生率在早期与后期之间相当。
要点
- 术后1年典型症状完全或部分控制率为90.3%,非典型症状为73.5%。
- 术后1年中度至重度吞咽困难、无法嗳气、腹胀和排气过多发生率分别为23.5%、29.4%、23.2%和22.0%。
- 2011至2018年韩国抗反流手术量持续增加,后期手术时间较早期显著缩短。
核心结论
- 腹腔镜抗反流手术治疗GERD有效,典型症状缓解率超过90%,术后并发症发生率与西方中远期随访研究相当。
- 该结果支持抗反流手术在韩国人群中作为GERD治疗的可行性与安全性。
研究设计与样本
- 基于韩国抗反流手术研究(KARS)全国队列,分析截至2018年接受抗反流手术的310例GERD患者。
- 按手术时期分为2014年及以前与2014年以后两组,比较患者特征与手术质量的变化趋势。
- 采用KARS设计的问卷在术后3个月和1年评估基线特征、症状缓解与并发症。
主要发现
- 术前典型症状见于275例(91.7%),非典型症状见于208例(71.0%)。
- 术后1年典型与非典型症状完全或部分控制率分别为90.3%和73.5%。
- 后期(2015-2018)食管裂孔疝患者比例和合并症增加(p < 0.01,p = 0.053),手术时间显著缩短(p < 0.01)。
- 两个时期的症状控制与并发症发生率相当。
临床怎么用
- 对于GERD患者,抗反流手术可获得较高的典型症状缓解率,可作为药物治疗之外的可行选择。
- 术后需关注吞咽困难、无法嗳气、腹胀和排气过多等并发症,并在随访中评估症状控制情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2014, the results derived from the nationwide data of the Korean Anti-reflux Surgery Study (KARS) demonstrated short-term feasibility and safety of anti-reflux surgery. This study aimed to update the longer-term safety and feasibility of laparoscopic anti-reflux surgery up to 1-year follow-up with the KARS nationwide cohort. METHODS: The data of 310 patients with GERD who received anti-reflux surgery up to 2018 were analyzed. Baseline patient characteristics, postoperative symptom resolution, and postoperative complications were evaluated at postoperative 3 months and 1 year using the questionnaire designed by KARS. We divided the patients into two groups according to the operation period (up to and after 2014) to identify changes in the trends of the characteristics of surgical patients and operative qualities. RESULTS: The typical preoperative symptoms were present in 275 patients (91.7%), and atypical symptoms were present in 208 patients (71.0%). Ninety-seven (35.5%) and 124 patients (46.1%) had inadequate PPI responses and hiatal hernia, respectively. At postoperative 1 year, typical and atypical symptoms were either completely or partially controlled in 90.3% and 73.5.0% of patients, respectively. Moderate-to-severe dysphagia, inability to belch, gas bloating, and flatulence at postoperative 1 year were identified in 23.5%, 29.4%, 23.2%, and 22.0% of patients, respectively. The number of surgical patients continuously increased from 2011 to 2018 in Korea. The proportion of patients with hiatal hernia and comorbidities increased (p < 0.01, p = 0.053), and the operation time decreased significantly (p < 0.01) in the late period (2015-2018) as compared with the early period (2011-2014). Symptom control and complication rate were equivalent between the two periods. CONCLUSIONS: Anti-reflux surgery was effective with > 90% of typical symptom resolution and posed a comparable postoperative complication rate with those in Western studies with mid-term to long-term follow-up. This result supports the feasibility and safety of anti-reflux surgery as a treatment for GERD in the Korean population.
引用
- Kim MS, Oh Y, Lee JH, et al. Trends in laparoscopic anti-reflux surgery: a Korea nationwide study. Surg Endosc. 2020. PMID: 32875418. doi:10.1007/s00464-020-07909-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。